Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HITC | Common Stock | Award | $167K | +1.52M | $0.11 | 1.52M | Jul 31, 2023 | Direct | F1 | |
transaction | HITC | Common Stock | Award | $25.8K | +258K | $0.10 | 258K | Jul 31, 2024 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | HITC | Holdings | 150K | Jul 31, 2024 | Common Stock | 150K | $0.40 | Direct | F3 | |||||
holding | HITC | Holdings | 283K | Jul 31, 2024 | Common Stock | 283K | $0.40 | Direct | F3 | |||||
holding | HITC | Holdings | 283K | Jul 31, 2024 | Common Stock | 283K | $0.40 | Direct | F3 | |||||
holding | HITC | Holdings | 283K | Jul 31, 2024 | Common Stock | 283K | $0.40 | Direct | F3 |
Id | Content |
---|---|
F1 | On July 31, 2023, the Board of Directors of the issuer approved the issuance of 1,516,666 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2023 under her Employment Agreement dated September 1, 2020. |
F2 | On July 31, 2024, the Board of Directors of the issuer approved the issuance of 258,360 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2024 under her Employment Agreement dated January 31, 2024. |
F3 | On September 1, 2020, the Reporting Person was appointed Chief Medical Officer of the issuer. Upon execution of an Employment Agreement dated on such date, the Reporting Person was awarded 1,000,000 common stock purchase options, all of which are currently vested. |